Changes Associated With the Entry of a Biosimilar in the Insulin Glargine Market.
Where this comes from
- Record sourced from PubMed, PMID 34180955.
- Also identified by DOI 10.1001/jamainternmed.2021.2769 and PMC identifier 8240006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study explores the shifts in total US sales and net prices for all 3 insulin glargine products from quarter 1 of 2010 through quarter 2 of 2020.
Medical subject headings
- Biosimilar Pharmaceuticals
- Diabetes Mellitus
- Drug Costs
- Insulin Glargine